]>
IRCT20200411047024N1 IRCT 2020-04-29 Shahroud University of Medical Sciences Evaluation effect of treatment with IM D3 on clinical, paraclinical symptoms and signs and inhospital outcome at patient admitted with coovid19 Evaluation effect of treatment with IM(intramuscular) D3 on clinical, paraclinical symptoms and signs and in-hospital outcome at patient admitted with coovid19 2020-05-21 anticipated 100 Complete https://irct.ir/trial/47093 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The allotment sequence is determined using the website. Block method 4 was used to determine the allocation sequence. White envelopes are used to hide the allocation sequence. In this way, each sequence is placed inside a white envelope and the envelopes are arranged side by side and we number the letters to don't be disorganized. For each eligible participant, an envelope will be opened and assigned to the desired group, Blinding description: White envelopes are used to hide the allocation sequence. In this way, each sequence is placed inside a white envelope and the envelopes are arranged side by side, and the patients take one envelope each in order of entering the design, and according to the letter in the envelope (A or B) are divided into two groups, and only the ward nurse knows that which group must receive the intervention, but the person in charge of data collection, the head of the laboratory and information analysis does not know which group received the intervention. 1-2 COIVD-19 patient. Intervention 1: Intervention group: Intramuscular Injection of 300 milligrams of vitamin D at the beginning of the week, as well as another dose at the beginning of the week. Intervention 2: Control group: This group are treated by normal treatment process without any intervention. Yes - There is a plan to make this available What will be shared: All data is made available to the public after unidentifiable identification When: Data access period begins 2 months after the article is published To whom: It will be available only to researchers working in academic and scientific institutions or to people working in the industry Conditions: They can do any kind of analysis with data. And the data can be used in any research direction, otherwise it must be coordinated with the researcher. Where to obtain: email:erfankazemi305@gmail.com number:0098 9155868605 How to obtain: Applicants can contact us by e-mail or the mentioned number to receive information. Comments:
public Erfan Kazemi
Shahroud University of Medical Sciences, 7 Tir Square, Shahroud
Shahrud Iran (Islamic Republic of) 36147-73947 +98 23 3239 5054 kazemi.e@shmu.ac.ir Shahroud University of Medical Sciences scientific hossien sheybani
Shahroud University of Medical Sciences, 7 Tir Square, Shahroud
Shahrud Iran (Islamic Republic of) 36147-73947 +98 23 3239 5054 shyebani@shmu.ac.ir Shahroud University of Medical Sciences Iran (Islamic Republic of) Individual satisfaction to participate in the project Confirmation of covid-19 disease by CPR test no limit no limit Both Vitamin D levels are more than 30 Nanograms /milliliter U07.1 covid-19, virus identified Treatment - Other N/A Intervention group: Intramuscular Injection of 300 milligrams of vitamin D at the beginning of the week, as well as another dose at the beginning of the week. Control group: This group are treated by normal treatment process without any intervention Clinical course. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: By recording information about the variables defined from the patients' hospital records. Paraclinical. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Registration of patient's laboratory information and CT scan. Outcome. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Doctor's approval and death certificate. Duration of hospitalization. Timepoint: End of hospitalization. Method of measurement: Hospital file. Severe chest pain. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Ask the patient. Severe shortness of breath. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Ask the patient. How many days after hospitalization they died. Timepoint: End of hospitalization. Method of measurement: ask the patient. Shahroud University of Medical Sciences Approved 2020-04-04 Ethics committee of Shahrud University of Medical Sciences Shahrud University of Medical Sciences, 7 Tir Square, Shahrud Shahrud Semnan Iran (Islamic Republic of)